The transcranial direct current stimulation over prefrontal cortex combined with the cognitive training reduced the cue-induced craving in female individuals with methamphetamine use disorder: A randomized controlled trial

Xu, Xiaomin; Ding, Xinni; Chen, Liyu; Chen, Tianzhen; Su, Hang; Li, Xiaotong; Ye, Yujian; Shi, Wen; Ji, Jie; Zhao, Min; Zhong, Na; Jiang, Haifeng

doi:10.1016/j.jpsychires.2020.12.056

Cited by 25 publications

(17 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 and Table S3). 17,21,23,24,31,44–116 Finally, 22 RCTs were included (Table S4). 13–16,117–134 Figure 2 illustrates the entire geometric distribution of the treatment arms.…”

Section: Resultsmentioning

confidence: 99%

Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: A network meta‐analysis of randomized controlled trials

Satogami

Liang

et al. 2022

Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Aim: In recent decades, the prevalence of amphetamine and methamphetamine use disorders has at least doubled in some regions/countries, with accompanying high risks of drug overdose-associated mortality. Noninvasive brain stimulation (NIBS) methods may be effective treatments. However, the comparative efficacy of the NIBS protocol for amphetamine/ methamphetamine use disorder (AUD/MUD) remains unknown to date. The aim of this network meta-analysis (NMA) was to compare the efficacy and acceptability of various NIBS methods/protocols for AUD/MUD management.Methods: A frequentist model-based NMA was conducted. We included randomized controlled trials (RCTs) that investigated the efficacy of NIBS and guideline-recommended pharmacologic treatments to reduce craving severity in patients with either AUD or MUD. Results: Twenty-two RCTs including 1888 participants met the eligibility criteria. Compared with the sham/placebo group (study = 19, subjects = 891), a combination of intermittent theta burst stimulation over the left dorsolateral prefrontal cortex (DLPFC) and continuous TBS over the left ventromedial prefrontal cortex (study = 1, subjects = 19) was associated with the largest decreases in craving severity [standardized mean difference (SMD) = À1.50; 95% confidence intervals (95%CIs) = À2.70 to À0.31]. Highfrequency repetitive transcranial magnetic stimulation over the left DLPFC was associated with the largest improvements in depression and quality of sleep (study = 3, subjects = 86) (SMD = À2.48; 95%CIs = À3.25 to À1.71 and SMD = À2.43; 95%CIs = À3.38 to À1.48, respectively).The drop-out rate of most investigated treatments did not significantly differ between groups. Conclusion:The combined TBS protocol over the prefrontal cortex was associated with the greatest improvement in craving severity. Since few studies were available for inclusion, additional large-scale randomized controlled trials are warranted.

show abstract

“…1 and Table S3). 17,21,23,24,31,44–116 Finally, 22 RCTs were included (Table S4). 13–16,117–134 Figure 2 illustrates the entire geometric distribution of the treatment arms.…”

Section: Resultsmentioning

confidence: 99%

Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: A network meta‐analysis of randomized controlled trials

Satogami

Liang

et al. 2022

Psychiatry Clin Neurosci

View full text Add to dashboard Cite

show abstract

“…The study findings are effective at a research level and it is not obvious if the findings can be effective at a population level. However, other studies have reported a positive effect of brain stimulation on craving [15,16,18,25]. Six-month, 12-month and 24-month follow ups are not part of the study design.…”

Section: Studies In Iran Indicate That Methamphetamine Cravingmentioning

confidence: 98%

Brain Stimulation and Methamphetamine in Iran: A Debate in the Most Populous Persian Gulf Country

Massah

2020

IRJ

View full text Add to dashboard Cite

Methamphetamine dependence has been known as a serious health problem in a large proportion of illicit drug users in Iran. Compared with the opium problem, methamphetamine dependence is a new epidemic concern in Iran. The prevalence of methamphetamine dependence is associated with crucial health problems such as poor psychological well-being, social dysfunction, craving, and a higher rate of addiction severity. This issue necessitates professional attention to the rehabilitation of methamphetamine users and treatment of craving. To date, few research studies have been conducted on this health concern. Studies in Iran indicate that methamphetamine craving shows resistance to treatment. While few pharmacological treatments have been found to be effective, motivational interviewing, matrix model and cognitive-behavioral therapy have been all evaluated in Iran to treat methamphetamine craving. However, the treatment effects need to be more long-lasting. Previous studies show that methamphetamine users lapse and relapse for a variety of reasons include “pleasure-seeking”/“impulsivity”/“habits”/“pain avoidance”/“craving”/“bad feelings eliminating such as boredom & loneliness” which have a strong neurological basis in the central nervous system and emotions and decisions that result from them. Thus we should use a range of different modalities to treat and prevent relapse.

show abstract

“…Similar to rTMS, tDCS significantly reduced METH craving and increased executive functions compared to controls [ 113 - 115 ], lasting throughout the treatment and at least up to 1-month post-treatment [ 114 ], despite differences in experimental conditions. The differences included the number of sessions and subjects, sex of the subjects, stimulated side of the DLPFC (right anodal/left cathodal or vice versa ), strength of the current, and type of controls (sham stimulation, treatment-as-usual or computerized cognitive addiction therapy).…”

Section: Current Treatments For Methamphetamine Use Disordermentioning

confidence: 99%

Current and Emerging Treatments for Methamphetamine Use Disorder

Moszczynska

2021

View full text Add to dashboard Cite

: Almost two decades have passed since the last methamphetamine (METH) abuse epidemic. In recent years, METH abuse in the US has been rapidly increasing and is currently one of the leading causes of death in our country. Available statistical data indicates re-emergence of METH popularity and suggest an impending third epidemic of METH abuse. Alarmingly, there is no FDA- approved medication for METH use disorder (MUD). This disorder is currently treated with behavioral therapies; however, these therapies have limitations and would benefit from the addition of a MUD pharmacotherapy. Unfortunately, clinical trials have not yet found consistently effective pharmacotherapy for MUD. This review outlines the history of METH use, provides information on current prevalence of METH abuse and MUD, describes medications that have been in clinical trials for MUD, and addresses current as well as potential new treatments for MUD.

show abstract

The transcranial direct current stimulation over prefrontal cortex combined with the cognitive training reduced the cue-induced craving in female individuals with methamphetamine use disorder: A randomized controlled trial

Cited by 25 publications

References 82 publications

Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: A network meta‐analysis of randomized controlled trials

Multiple comparison of different noninvasive brain stimulation and pharmacologic interventions in patients with methamphetamine use disorders: A network meta‐analysis of randomized controlled trials

Brain Stimulation and Methamphetamine in Iran: A Debate in the Most Populous Persian Gulf Country

Current and Emerging Treatments for Methamphetamine Use Disorder

Contact Info

Product

Resources

About